• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Annovis Bio, Inc. Common Stock (NY:ANVS)

2.510 -0.220 (-8.06%)
Official Closing Price Updated: 7:00 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 349,751
Open 2.700
Bid (Size) 2.500 (2)
Ask (Size) 3.040 (1)
Prev. Close 2.730
Today's Range 2.360 - 2.719
52wk Range 1.110 - 10.54
Shares Outstanding 19,486,231
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Medpace Shares Are Trading Higher By 45%; Here Are 20 Stocks Moving Premarket
July 22, 2025
 
Via Benzinga
BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) to Present Alzheimer’s Advances at AAIC 2025 in Toronto
June 26, 2025
Via Investor Brand Network

Performance

YTD
-50.9%
-50.9%
1 Month
+6.4%
+6.4%
3 Month
+61.9%
+61.9%
6 Month
-22.5%
-22.5%
1 Year
-71.0%
-71.0%

More News

Read More
Annovis to Attend the AAIC 2025 with Four Poster Presentations
June 26, 2025
From Annovis Bio Inc.
Via GlobeNewswire
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
June 25, 2025
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 25, 2025
Via Benzinga
Let's have a look at the top gainers and losers in the middle of the day of today's session.
June 25, 2025
Via Chartmill
InvestorNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Gains 18-Month NYSE Compliance Window
June 20, 2025
Via Investor Brand Network
Topics Regulatory Compliance
Annovis Announces NYSE Acceptance of Plan to Regain Listing Compliance
June 19, 2025
From Annovis Bio Inc.
Via GlobeNewswire
BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) to Host Webcast With CEO to Share Updates on Alzheimer’s and Parkinson’s Programs
June 05, 2025
Via Investor Brand Network
Annovis to Host Webinar and Live Q&A on June 24, 2025
June 05, 2025
From Annovis Bio Inc.
Via GlobeNewswire
Which stocks are experiencing notable movement on Wednesday?
June 04, 2025
Via Chartmill
Levi Strauss To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Thursday
May 15, 2025
Via Benzinga
BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Advances Phase 3 Alzheimer’s Trial and Expands Conference Presence in Q1
May 14, 2025
Via Investor Brand Network
Topics Intellectual Property
Annovis Provides Corporate Updates and Reports First Quarter 2025 Financial Results
May 13, 2025
From Annovis Bio Inc.
Via GlobeNewswire
InvestorNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Appoints Hui Liu as Director of Biostatistics
April 29, 2025
Via Investor Brand Network
Annovis Bio Appoints Hui Liu as Director of Biostatistics
April 29, 2025
From Annovis Bio Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
April 21, 2025
Via Benzinga
Here are the top movers in Monday's session.
April 21, 2025
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
April 21, 2025
Via Benzinga
InvestorNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Receives NYSE Noncompliance Notice Over Market Cap and Equity Levels
March 28, 2025
Via Investor Brand Network
Annovis Bio, Inc. Receives Continued Listing Standard Notice From the NYSE
March 27, 2025
From Annovis Bio Inc.
Via GlobeNewswire
BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) to Present Late-Stage Alzheimer’s and Parkinson’s Data at AD/PD 2025
March 25, 2025
Via Investor Brand Network
Annovis to Attend AD/PD™ 2025 with Extensive Scientific Program
March 25, 2025
From Annovis Bio Inc.
Via GlobeNewswire
InvestorNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Advances Alzheimer’s and Parkinson’s Pipeline, Launches Pivotal Phase 3 Trial
March 24, 2025
Via Investor Brand Network
Topics Intellectual Property
Annovis Provides Corporate Updates and Reports Fourth Quarter and Fiscal Year 2024 Financial Results
March 21, 2025
From Annovis Bio Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Annovis Bio, Inc. Common Stock publicly traded?
Yes, Annovis Bio, Inc. Common Stock is publicly traded.
What exchange does Annovis Bio, Inc. Common Stock trade on?
Annovis Bio, Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Annovis Bio, Inc. Common Stock?
The ticker symbol for Annovis Bio, Inc. Common Stock is ANVS on the New York Stock Exchange
What is the current price of Annovis Bio, Inc. Common Stock?
The current price of Annovis Bio, Inc. Common Stock is 2.510
When was Annovis Bio, Inc. Common Stock last traded?
The last trade of Annovis Bio, Inc. Common Stock was at 08/01/25 07:00 PM ET
What is the market capitalization of Annovis Bio, Inc. Common Stock?
The market capitalization of Annovis Bio, Inc. Common Stock is 48.91M
How many shares of Annovis Bio, Inc. Common Stock are outstanding?
Annovis Bio, Inc. Common Stock has 49M shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap